BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 18217139)

  • 1. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.
    Ray DM; Spinelli SL; Pollock SJ; Murant TI; O'Brien JJ; Blumberg N; Francis CW; Taubman MB; Phipps RP
    Thromb Haemost; 2008 Jan; 99(1):86-95. PubMed ID: 18217139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression.
    Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE
    Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors.
    Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T
    Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.
    Akbiyik F; Ray DM; Gettings KF; Blumberg N; Francis CW; Phipps RP
    Blood; 2004 Sep; 104(5):1361-8. PubMed ID: 15130939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling.
    Sahler J; Woeller C; Spinelli S; Blumberg N; Phipps R
    J Thromb Haemost; 2012 Dec; 10(12):2563-72. PubMed ID: 23039852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
    Konopleva M; Elstner E; McQueen TJ; Tsao T; Sudarikov A; Hu W; Schober WD; Wang RY; Chism D; Kornblau SM; Younes A; Collins SJ; Koeffler HP; Andreeff M
    Mol Cancer Ther; 2004 Oct; 3(10):1249-62. PubMed ID: 15486192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microparticles engineered to highly express peroxisome proliferator-activated receptor-γ decreased inflammatory mediator production and increased adhesion of recipient monocytes.
    Sahler J; Woeller CF; Phipps RP
    PLoS One; 2014; 9(11):e113189. PubMed ID: 25426628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
    Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
    Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
    Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
    ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peroxisome proliferator-activated receptor gamma-retinoid X receptor heterodimer physically interacts with the transcriptional activator PAX6 to inhibit glucagon gene transcription.
    Krätzner R; Fröhlich F; Lepler K; Schröder M; Röher K; Dickel C; Tzvetkov MV; Quentin T; Oetjen E; Knepel W
    Mol Pharmacol; 2008 Feb; 73(2):509-17. PubMed ID: 17962386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets.
    Moraes LA; Swales KE; Wray JA; Damazo A; Gibbins JM; Warner TD; Bishop-Bailey D
    Blood; 2007 May; 109(9):3741-4. PubMed ID: 17213293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition.
    Dong YW; Wang XP; Wu K
    World J Gastroenterol; 2009 Jan; 15(4):441-8. PubMed ID: 19152448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.
    Shalom-Barak T; Liersemann J; Memari B; Flechner L; Devor CE; Bernardo TM; Kim S; Matsumoto N; Friedman SL; Evans RM; White JH; Barak Y
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intact DNA-binding domain is not required for peroxisome proliferator-activated receptor gamma (PPARgamma) binding and activation on some PPAR response elements.
    Temple KA; Cohen RN; Wondisford SR; Yu C; Deplewski D; Wondisford FE
    J Biol Chem; 2005 Feb; 280(5):3529-40. PubMed ID: 15572375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.
    Desreumaux P; Dubuquoy L; Nutten S; Peuchmaur M; Englaro W; Schoonjans K; Derijard B; Desvergne B; Wahli W; Chambon P; Leibowitz MD; Colombel JF; Auwerx J
    J Exp Med; 2001 Apr; 193(7):827-38. PubMed ID: 11283155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα.
    Choi JS; Choi SS; Kim ES; Seo YK; Seo JK; Kim EK; Suh PG; Choi JH
    Cell Signal; 2015 Mar; 27(3):614-20. PubMed ID: 25479590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.
    Ray DM; Spinelli SL; O'Brien JJ; Blumberg N; Phipps RP
    BioDrugs; 2006; 20(4):231-41. PubMed ID: 16831022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
    Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M
    Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.